Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice

Neuroscience Letters

Volumn 406, Issue 1-2, 2006, Pages 17-22

  Rünkorg, Kertu ^a   Värv, Siim ^a   Matsui, Toshimitsu ^b   Kõks, Sulev ^a   Vasar, Eero ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amphetamine; CCK2 receptors; Conditioned place preference; Dopamine related genes; Genetic invalidation; Motor sensitization

Indexed keywords

AMPHETAMINE; CHOLECYSTOKININ B RECEPTOR; DOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOWN REGULATION; DRD1 GENE; DRD2 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HOMOZYGOSITY; LIMBIC SYSTEM; LOCOMOTION; MESENCEPHALON; MOTOR ACTIVITY; MOTOR PERFORMANCE; MOUSE; MOUSE STRAIN; NEUROBIOLOGY; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; SENSITIZATION; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; TYHY GENE; UPREGULATION; WILD TYPE;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHOLECYSTOKININ; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; GENE EXPRESSION REGULATION; HOMOZYGOTE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, DOPAMINE; TYROSINE 3-MONOOXYGENASE; UP-REGULATION; VENTRAL TEGMENTAL AREA;

EID: 33747792675     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.07.016     Document Type: Article

References (19)

1. Alttoa A., and Harro J. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine. Eur. Neuropsychopharmacol. 14 (2004) 324-331
2. Carr G.D., and White N.M. Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study. Psychopharmacology 89 (1986) 340-346
3. Dalia A., Uretsky N.J., and Wallace L.J. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity. Brain Res. 788 (1998) 111-117
4. Dauge V., Beslot F., Matsui T., and Roques B.P. Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine. Neurosci. Lett. 306 (2001) 41-44
5. Elmer G.I., Pieper J.O., Levy J., Rubinstein M., Low M.J., Grandy D.K., and Wise R.A. Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Psychopharmacology 182 (2005) 33-44
6. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego, London
7. Gerdeman G.L., Partridge J.G., Lupica C.R., and Lovinger D.M. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 26 (2003) 184-192
8. Hökfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., and Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 285 (1980) 476-478
9. Koks S., Volke V., Veraksits A., Runkorg K., Islet T., Abramov U., Bourin M., Huotari M., Mannisto P.T., Matsui T., and Vasar E. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Psychopharmacology 158 (2001) 198-204
10. (T)) method. Methods 25 (2001) 402-408
11. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., and Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388 (1997) 586-589
12. Miyasaka K., Hosoya H., Takano S., Ohta M., Sekime A., Kanai S., Matsui T., and Funakoshi A. Differences in ethanol ingestion between cholecystokinin-A receptor deficient and -B receptor deficient mice. Alcohol Alcohol. 40 (2005) 176-180
13. Nagata A., Ito M., Iwata N., Kuno J., Takano H., Mimosa O., Chihara K., Matsui T., and Noda T. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11825-11830
14. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. 12 (1992) 2439-2450
15. Pettit H.O., and Mueller K. Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine conditioned place preferences. Psychopharmacology 99 (1989) 423-426
16. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev. 25 (1997) 192-216
17. Runkorg K., Veraksits A., Kurrikoff K., Luuk H., Raud S., Abramov U., Matsui T., Bourin M., Koks S., and Vasar E. Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice. Behav. Brain Res. 144 (2003) 125-135
18. Vasar E., Harro J., Lang A., Pold A., and Soosaar A. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse. Psychopharmacology 105 (1991) 393-399
19. Wunderlich G.R., DeSousa N.J., and Vaccarino F.J. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat. Psychopharmacology 151 (2000) 283-290